 285-298 (1996) 
Introduction
Considerable progress has been made exposure to a physical or chemical agent over the past two decades in the validity produces significant changes in neuroassessment of a variety of response end behavioral development [for reviews points in experimental behavioral teratol-of methods and results, see (1) (2) (3) (4) (5) (6) (7) (8) (9) ; for ogy, i.e., in studies that are aimed at proceedings of ad hoc meetings, see verifying whether prenatal or postnatal (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) ].
A first distinction that needs to be made is that behavioral teratology assessments must often be performed with different background information, under different conditions, and sometimes with different goals, depending on the agent considered. In the case of pharmaceutical drugs, for example, the information on biological effects and mechanisms of action, body burden, and other important properties is generally much more extensive than in the case of industrial chemicals. Moreover, in the case of medicines the routine routes of exposure (po or ip) can generally suffice in most investigations, and negative results are only moderately useful; in the case of industrial agents, inhalation or percutaneous exposure often need to be considered, and negative and positive results are equally useful (20) .
Since the early work in behavioral teratology (21) , economical test methods have made a substantial contribution to risk assessment; in addition, they have often provided information that can be readily translated into useful working hypotheses concerning the significance and the nature of the effects observed, which is essential for deciding whether higher-tier studies are necessary. Moreover, these methods have played a major role in collaborative studies aimed either at checking the replicability of the results by experiments performed in different laboratories under identical conditions (22) or at widening the range of assessments after a specified treatment by subdividing the test burden between different laboratories (23) .
Behavioral teratology covers a very broad area that includes at one end the study of behavioral changes produced by treatments whose teratogenic effects are clearly documented by neuropathological assessments, as is the case with quite different agents such as methylmercury (MM), methylazoxymethanol (MAM) , and ethanol. Even in these extreme cases, animal behavior studies can play an essential role in the detection and definition of changes produced by exposures to doses or concentrations whose effects are below the threshold of neuropathological methods. In humans, this applies to children exposed either in utero to low doses of ethanol (24, 25) or prenatally and postnatally to low doses of lead (26) . In both instances, human and animal data have been shown to be in good agreement with each other (27, 28) .
At the opposite end, behavioral teratology studies are essential to assess possible risks created by exposures to agents that do not have a substantial teratogenic potential as assessed by the use of somatic end points. The continuing discussion on the teratogenic potential of drugs such as some of the antiepileptics and anxiolytics shows that the distinction between teratogenic and nonteratogenic agents cannot be a sharp one; however, there are considerable differences (both qualitative and quantitative) between the CNS damage produced by prenatal exposure to these drugs and that produced by agents such as MM, MAM, and ethanol (at high doses). In addition, information on the short-and long-term biochemical effects produced by agents of both types is not readily amenable to an interpretation in the absence of behavioral assessments or when negative behavioral data or minimal changes are found after treatments that produce considerable CNS changes [see (29) for ethanol; (30) for parathion; (31) for methyl demeton (Meta-Systox)].
Essentially, behavioral investigations must be sufficiently extensive and specific to assess the meaning of observed correlations or, at least, to help identify the mechanisms that induce a behavioral expression of a given CNS change in some situations, but not in others. For example, the dosedependent increase in preweaning locomotor activity observed in rats after prenatal anticonvulsant (phenytoin) treatment when using a square open field failed to occur in the same laboratory when using a circular field (32) . Neonatal antidepressant (clomipramine) treatment resulted in open-field hyperactivity at the adult stage, whereas activity in a closed chamber was not affected; this suggested that hyperreactivity to mild stress was the cause of the former change (33) . In the case of haloperidol treatment on postnatal days 4 to 21, which is known to produce considerable effects on CNS dopaminergic mechanisms, mice did not show activity changes in a photocell activity cage, in a circular alley, and in an operant chamber. However, activity was significantly increased in a presumably more stressful situation (the open field), but only in 4 out of 12 combinations of animal strain, age, and time of testing (34) . These examples of complex interaction profiles should not be construed as an obstacle to the use of simple and economical assessment procedures. The experimenter, however, should be aware of the frequent occurrence of such interactions so as to understand the risk of false negatives and false positives and to be able to decide whether more complex and expensive higher tier assessments are a real need or, vice versa, a useless luxury.
The emphasis on the need for adequate behavioral investigation does not mean that any deviation from the behavioral profile of control animals is to be interpreted as a sign of pathology (see section "Pain Reactivity and Analgesic Drug Effects" for some indications on response variation produced by a variety of early influences). Specifically, several types of isolated behavioral changes can be essentially neutral with respect to adequate functioning of homeostatic processes; this, for example, is likely to be the case with changes in activity levels when the scores of all treated subjects remain within the range of the control population, and other types of changes are consistently absent. At the present state of the art, no rule of thumb is available to separate the normal from the pathological in borderline cases; therefore, any reproducible behavioral change of less than negligible size should be taken as a warning that the agent causing it may require a more thorough assessment.
The survey of economical test methods will be preceded by some considerations concerning inference strategies While the additional information provided by subsequent higher tier studies cannot be discussed here, this example confirms that a heavy test burden is not a qua non to combine risk assessment and a preliminary evaluation of treatments' mechanisms of action. In the case of benzodiazepines, information on the latter point turned out to be of potential value when recent data showed borderline neuropsychological deficits in children exposed prenatally to these agents (37) .
As concerns the choice of an appropriate strategy in behavioral teratology studies, two factors must be considered jointly, i.e., the goals of a particular project (39) .
Postnatal Sensory and Motor Development
The rat and the mouse are altricial species, that is, the pups are born in a highly immature condition after a short pregnancy (18-22 days, depending on species and strain). At birth, the eyes and ears are closed, the pup is able to crawl, and to get attached to a nipple and to suckle, while it needs close body contact with the mother for purposes of thermoregulation. Several reflexes and responses appear at successive postnatal stages in parallel with somatic changes, progressively increasing the pup's sensory and motor capabilities and, afterwards (particularly after eye opening around the end of the second postnatal week), its ability to procure food and -fluid. (44) . The description given below represents a slightly modified version of the original scale to include some additional measures (strong and weak tactile stimulation tests) (35) .
The most common procedure is to test each animal daily to avoid time lags in the detection of a maturational event. However, little is known about the effects of different handling and testing burdens on subsequent maturation of the various reflexes and responses, although handling is recognized as a crucial variable.
In the list that follows, the postnatal ages at which a reflex or response first appears and subsequently shows complete maturation (i.e., aduldike characteristics) have been intentionally omitted [for representative illustrations of the absence or presence of a delay in postnatal neurobehavioral development after prenatal 03 or benzodiazepine exposure, respectively, see (40, 51) ]. In fact, it appears essential that each experimenter establish and repeatedly verify control baselines specific for the conditions under which the work is conducted, including animal strain, types of control treatments (depending on exposure schedules), and scoring system adopted (see above). In addition to assessing the neurobehavioral end points indicated below, it is also essential to perform a parallel assessment of somatic developmental end points, including at least body weight gain and time of eye opening, ear opening, and incisor eruption. These neurobehavioral end points of the Fox Scale are as follows: a) righting reflex-pup returns to its feet when placed on its back; b) cliff aversion-pup withdraws from the edge of a flat surface when its snout and forepaws are placed over the cliff; c) forelimb and hindlimb stick grasp reflex-pup grasps the shaft of a toothpick when it is touched to the palm of each paw; d) vibrissa placing reflex-pup places its forepaw on a cotton swab stroked across its vibrissae; e) level or vertical screen test-pup holds onto a wire mesh (5 x 5 mm) when dragged across it horizontally or vertically by the tail; f) screen climbing test-pup climbs up the vertical screen using both fore-and hindpaws; g) pole grasping-pup grips a wooden pencil with its forepaws; h) auditory startle response-pup shows a whole-body startle response when a loud clap of the hands occurs less then 10 cm away; and i) strong and weak tactile stimulation tests-a headturning response is triggered by the application of tactile stimuli (von Frey hairs of 0.35 or 0.05 g) in the perioral area on both sides of the head.
No attempt can be made here to review the ample literature concerning the effects of various early treatments on postnatal neurobehavioral development as assessed by functional observational batteries like the one illustrated above. One problem is that batteries with more than a few end points, while yielding consistent results in the same laboratory over an extended period of time, have apparently not been included in interlaboratory comparisons.
As concerns other problems, one can mention the differences in treatment effects between strains of the same species. In one study, phenobarbital treatment on days 10 to 16 of gestation delayed postnatal sensory-motor development in mice of the DBA strain, whereas drug-exposed mice of the C57BL/6J strain were unaffected or slightly quicker in attaining mature responses in some tests (52) . The considerable strain difference in response to treatment was also confirmed by the fact that only the DBA mice developed hyperactivity (up to three times the control level at 18 days); in addition, the profile of changes in uptake of neurotransmitters by cerebral cultures established with tissue removed shortly after the end of prenatal treatment differed markedly between the two strains.
Other Test
A variety of other tests that have been used to assess the pup's neurobehavioral capabilities at successive developmental stages cannot be described and evaluated here in any detail; these tests are often aimed at a more thorough evaluation of maturation phenomena that are subjected to quick and approximate assessment in batteries like the Fox scale. This applies, for example, to conventional assessments of motor coordination such as the rotarod test, which has a long tradition of use in pharmacology-toxicology, as well as to assessments of startle responses and startle habituation, which were included in the Collaborative Behavior Teratology Study (22) [for a review of reflexive measures, see (53) that alcohol-exposed pups moved closer to the warm end of a thermocline than did control pups; their body temperature, however, did not rise concurrently (55) .
Still other tests cannot claim the renown created by extensive use, but two of them deserve a brief description because they are quite economical and are apparently able to provide information at least somewhat different from that obtained by the tests so far discussed.
Suckling Test. This procedure has been extensively used in rats for a variety of developmental psychopharmacological assessments (56) ; more recently, it has been used in mice in order to assess the effects of a previous NGF treatment, induding those on psychopharmacological reactivity (57) . The test can be performed at different ages after birth and uses the anesthetized pup's own dam in order to assess the responses to the suckling stimulus; these indude attachment to the nipple and several other behaviors such as paddling with forelimbs, treading with hindlimbs, nipple shifting, and displacing a sibling from a nipple.
Homing Test. This test exploits the strong tendency of the immature pup to maintain body contact with the dam and the siblings, which requires adequate sensory (olfactory) and motor capabilities as well as the associative and discriminative capabilities that allow the pup to become imprinted by the mother's odor, to remember it, and to recognize it among others. In a version evolved for 10-day-old mice (51), the pup is placed at one end of a rectangular arena (36 x 22.5 cm) with a wire mesh floor and a goal area at the opposite end (14x22.5 cm). Shavings from the home litter are evenly spread under the floor of the latter area. The score is the time taken by the pup to place both forelimbs above the goal area. In the version most often used in rats, the pup is placed on the divide between the areas over home and clean bedding, and the time spent over each area is measured (58, 59 (62, 63) but also by nonstressful manipulations, such as variation of litter gender composition (64, 65) .
The interest for behavioral toxicology and teratology of these plasticity phenomena has been considerably enhanced by recent information concerning underlying mechanisms. In fact, hyperalgesia has been shown both in NGF-treated adult mice (66) and in transgenic mice that make excess NGF and have overgrown sympathetic neurons that make contact with sensory neurons [Davis et al., unpublished data; (67) ]. Therefore, changes in the dynamics of growth factors should be considered when a toxicological profile includes modifications in pain sensitivity.
Without attempting a review of the literature on the effects of early treatments, it must be mentioned that several experiments have shown short-and long-term effects of prenatal and postnatal treatments with opiate drugs (particularly morphine and methadone) on pain reactivity and responses to analgesics, including opposite effects on sensitivity to morphine (68) (69) (70) (71) . One of these studies has documented an interaction in rats between treatment and sex (that is, morphine hypersensitivity in males and hyposensitivity in females) with tests performed an extended period of time after the termination of morphine treatment on postnatal days 1 to 7. Moreover, the specificity of these effects was supported by the finding that both opioid stress analgesia after intermittent coldwater swims and nonopioid analgesia after continuous swims were little affected by the early treatment (70) .
The literature on other potential behavioral teratogens is more scattered but contains some interesting indications; for example, the analgesic effect of morphine was found to be enhanced by exposure to lead throughout pregnancy and lactation (72) . On the other hand, as emphasized in a previous section, negative data like those concerning the development of morphine analgesia after prenatal benzodiazepine treatment can provide a useful contrast when attempting to understand the mechanisms of production of other treatment effects (35 Specifically, the expectation is to obtain an average of one such value out of 20 tests, in the absence of any real effect, if the cut-off point is p = 0.05.
Given the scope of the present review, no attempt can be made to discuss when and how to escalate from univariate to multivariate analyses in experiments with multiple response end points. The experimenter performing first-tier risk assessments must know that the data obtained in these studies can gain considerable additional value when the statistical advisor is able to single out databases whose features make multivariate analysis worth the additional burden (to be borne by the advisor, of course, not by the experimenter). In fact, the art of characterizing and comparing effect profiles produced by behavioral teratology studies is still in its infancy. Therefore, the experimenter involved in first-tier risk assessments on poorly known agents is an ideal provider of new and original databases that can serve to verify the value of alternative multivariate models for the purpose of subsequent standardization.
Open Field
The open field is a typical all-purpose observational test, which imposes a considerable workload; therefore its cost-effectiveness ratio depends jointly on labor cost and the value attached to information provided by multiple response end points. The test is performed in a circular or square arena with a washable floor that needs to be thoroughly cleaned after each test. The size of the arena must be adjusted to both animal species and age. In the case of mice, for example, we now use a square (40 x 40 cm) arena for 10-to 30-day-old subjects (77) . In the case of rats, a typical size is 60 x 60 cm, which has proved suitable for testing animals of different ages (78) .
Whatever species and test conditions are used, open field tests must be performed under closely controlled conditions of illumination, background noise, and layout of landmarks outside the arena (e.g., the room furniture, any other object of more than minimal size, and the experimenter's location). As (78) .
As concerns the scoring of responses other than locomotor activity and the use of multiple response data, the list of potential end points is a fairly long one, including locomotion (crossings between squares), rearing (wall rearing and nonsupported), grooming, exploratory sniffing, freezing, time spent lying still (without freezing), time spent in contact or not in contact with the walls, various stereotypes (i.e., increase to above a zero or very low control level of acts such as face washing, gnawing, circling, jumping, head scanning, and focused sniffing), digging and push digging (if the floor is covered with bedding material), urination, and defecation.
If responses are scored during the test, no more than three to four of them should be included in the protocol to minimize the risk of observer errors; the suggestion is to focus the attention on locomotion, rearing, grooming, and stereotypies that can reveal noxious effects of the treatment under study or must be scored as part of a pharmacological reactivity assessment [see Laviola et al. (79) (80) .
Activity assessments are also performed in test environments with greater complexity and more elaborate scoring systems that consider both different responses and different sequences of the same response. For example, extensive use has been made-of the Figure-8 maze, which consists of several interconnected alleys forming the figure and intended to mimic the burrows of the rat's natural habitat (81) . This test environment, which tends to elicit high levels of spontaneous motor activity, has been exploited in several studies, including the Collaborative Behavior Teratology Study (22) . In the Collaborative Behavior Teratology Study, the profiles of prenatal treatment effects on activity were assessed by testing at different ages and for different durations (including responses to an amphetamine challenge); these profiles have shown considerable variation among different laboratories, particularly in prenatal d-amphetamine treatment conditions. Comparable attempts to analyze interlaboratory variation in the results of other activity tests are not available; therefore, the variability of Figure-8 maze results in the study just mentioned should not be construed as an indication against the further use of this test.
Other tests also exploit complex environments, as is the case with the holeboard test, which is aimed at separating activity (mainly locomotion) from exploration (dipping the head into the holes drilled in the cage floor). This and other similar distinctions are essentially anthropomorphic ones and fail to provide adequate cues to the understanding of responserelated differences in treatment effects, which need to be analyzed and interpreted by more objective criteria.
Representative Treatment Effect and Interacdons
This section provides a selection of representative treatment effects and interactions (with test factors per se on one side and organismic factors such as animal strain, sex, and age of testing on the other), including information on responses to drug challenges after treatments at early developmental stages (35, (82) (83) (84) (85) .
A preliminary consideration is that, before any behavioral teratology study, developmental trends of activity and responses to drug challenges need to be assessed and verified for replicability more thoroughly than other end points that have a lesser tendency to vary, like those illustrated in the section on postnatal sensory and motor development. Later on, repeated cross-checks between controls in a particular experiment and in previous experiments (historical controls) are equally essential. In fact, several data document both reassuring analogies between developmental trends in the presence of potentially strong sources of variation and unexpected deviations from apparently well-established developmental profiles.
At one extreme, for example, five inbred mouse strains with quite different activity profiles were shown to be highly uniform with respect to the appearance of antimuscarinic (scopolamine) hyperactivity at the end of the third postnatal week (86 At the opposite extreme, the experimenter can be faced with unexpected dissociations between developmental events that in several previous experiments had always been closely related to each other in spite of differences in species and test conditions. For example, in an experiment using different test schedules in the same open field, rat pups exposed to a single 30-min session showed only minimal within-session habituation at 3 weeks and full-fledged habituation at 4 weeks; at the latter time, however, scopolamine was still without effect and full-fledged drug hyperactivity was found only 2 weeks later. Even more surprisingly, exposure to three brief (5-min) sessions at 24-hr intervals allowed a near-complete between-session habituation to appear at 3 weeks, but no scopolamine effect was seen at 3, 4, or 6 weeks (78) .
Previous data had indicated that the maturation of scopolamine effects on other responses could occur much later than that of its effects on locomotor hyperactivity (87) . However, the data now available on the age-and test-dependent effects of this and other drug challenges, particularly amphetamine (78) , strengthen the notion that the response factor can account for only part of the observed variation in developmental activity profiles and drug reactivity.
This indicates two things: the maturation of a given neural mechanism can be revealed by the earliest age at which a stimulant or an antimuscarinic treatment produces marked locomotor hyperactivity, but functional reliance on the same mechanism for the modulation of the same response under different conditions (or of other responses) can develop only later. Ontogenetic dissociations of the two types of phenomena probably depend on the developmental pace of other interacting mechanisms whose role varies from one situation to the other.
This tentative model can help us understand the maturation phenomena exploited in behavioral teratology studies, which are related to specific new needs of the developing organism each time it moves on from one ecological niche to a new one (in the case of altricial rodents, for example, at the time of eye and ear opening and at the time of weaning). The methodological implications are not only for higher tier studies but also to first-tier risk assessments, for reasons of efficacy and economy. In fact, the experimenter should verify that the chosen combinations of activity test conditions and drug challenges are suitable for picking up critical developmental events at the time of their earliest possible occurrence, such as an activity surge and an increase in sensitivity to monoaminergic psychostimulants around the end of the second postnatal week and the appearance of adultlike habituation and scopolamine hyperactivity about 1 week later. In fact, any treatment effect on the development of the neural mechanisms responsible for these changes could be missed if test conditions delay the onset of functional reliance on these mechanisms and the changes produced by the treatment under study tend to be attenuated as the animal grows older.
Another methodological implication involves some important gaps in our knowledge concerning early treatment effects on developmental trends of drug reactivity. Specifically, several behavioral teratology studies have verified that useful information can be obtained by the use of monoaminergic drugs (particularly amphetamine, apomorphine, and cocaine), cholinergic-muscarinic agonists and antagonists, opiatergic drugs, and benzodiazepine receptor ligands. By contrast, the properties of other classes of agents have not yet been effectively exploited; the most obvious example is represented by 5-HT agonists and antagonists, whose effects at successive developmental stages have been carefully studied (88, 89) . This may be due to the fact that the wide range of types and subtypes in these drug classes makes it difficult to effect a rational choice of a highly restricted number of drug challenges under the constraints of behavioral teratological assessments.The most obvious of these constraints is the need to have all challenges and appropriate controls represented within each litter in each treatment-test age combination, in order to avoid the confounding of treatment and litter factors.
Overall, the increasing diversification within all classes of model drugs awaits exploitation in a more thorough analysis of early treatment effects and mechanisms of action on the basis of normative data concerning psychopharmacological reactivity during development; the effectiveness of this analysis is shown, for example, by the different effects of selective p-, k-, and &-opioid agonists in neonatal rats (90) . The nature of the interactions observed when studying early treatment effects on activity and drug reactivity can be further illustrated by the data concerning two well-known neurotoxicants, MM and ethanol, and an environmental pollutant, 03, which is devoid of major neurotoxic effects but can produce subtle and selective behavioral changes.
Methylmercury (MM). As early as
1978, Hughes and Sparber (91) showed that, in the absence of prenatal MM effects on operant response levels (essentially a measure of spontaneous activity) and on acquisition of an autoshape task, MM subjects showed an attenuation of the disrupting amphetamine effects on autoshaped behavior.
In a series of studies by Annau, Cuomo, and co-workers (92) (93) (94) , rats were given 5 to 8 mg/kg MM (po) on day 8 or 15 of pregnancy; open field activity at various postnatal ages was apparently not affected. The role of test factors, however, is suggested by the results of another study in the same series (95) , which showed hyperactivity at 4 to 15 days with a different test using a closed activity cage. More importantly, the former studies showed an enhancement of amphetamine hyperactivity in the open field and an enhancement of both apomorphine sniffing and apomorphine depression of activity in the MM offspring. These effects tended to become attenuated after the second or third postnatal week and were related to an increased density of dopamine receptors, whereas clonidine effects on activity and the profile of cortical 2-adrenoreceptors were not modified.
In the Collaborative Behavior Teratology Study (22) , involving six laboratories, there was more variation in the effects of prenatal MM (2 or 6 mg/kg po on gestational days 6-9) on Figure-8 (29, 102) . Because the latter study (102) Other data, however, contradict at least in part the inferences just mentioned. In one study, for example, ethanol-treated offspring showed an enhanced amphetamine hyperactivity (103) ; in another study a similar sensitization was found with a methylphenidate challenge (104) . In addition, a dose-response shift to the left for locomotor activity has been found in ethanol-treated rat offspring with apomorphine (105) .
In the first of these studies (103) , males at 4 weeks of age dearly showed the change in amphetamine reactivity but females did not; this is of considerable interest in the light of the growing evidence on early sex dimorphism of monoaminergic regulatory systems (79) . Moreover, the same study achieved a separation of the effects of ethanol from those of an important confounding variable by the use of a yoked control group that received sucrose substituted isocalorically for ethanol. Specifically, the ethanol enhancement of amphetamine reactivity in 4-week-old males failed to occur in the yoked group, whereas both the ethanol-treated and the yoked animals of both sexes showed a reduced amphetamine response at 6 weeks of age.
Considering the extraordinary importance of adequately understanding the developmental effects of subteratogenic doses of ethanol, the data mentioned so (40) .
Subsequent studies in mice used more prolonged 03 exposure, up to 0.6 ppm, from several days before the start of pregnancy until either day 17 of pregnancy (110) or weaning of the offspring 3 weeks after birth (77) , with or without cross-fostering at birth, respectively. Both exposure schedules again failed to affect postnatal neurobehavioral development, in spite of a marked and long-lasting depression of postnatal body weight gain in the study with combined gestational and postnatal treatment. The offspring exposed prenatally but not postnatally also failed to show changes in young adult activity or habituation in the automated test mentioned above. However, observational social interaction tests performed at 23 to 25 and 43 to 45 days on paired animals in the same test environment showed significant changes in response profiles; these consisted mainly of a reduction of locomotion and other exploratory movements (such as rearing and sniffing at the air, the walls, or the sawdust on the floor), which was paralleled by a significant increase in self-grooming. By contrast, several responses directed to the partner (such as sniffing, following, grooming, etc.) were not affected by prior 03 exposure (110) .
The effects of combined gestational and postnatal exposure on response profiles in two different observational tests and an automated test were more pronounced but equally selective (77) . An open-field test (40x40 cm arena) at 24 days in 03-exposed mice showed an attenuation or elimination of sex differences, i.e., a reduction of the higher female scores to male levels in the case of rearing and a convergence of both female (lower) and male (higher) scores toward the overall average in the case of sniffing. Third, the failure to locate treatmentsex interactions in the second observational test warns against an excessive reduction of final group size. In fact, as is well known, the power of ANOVA F tests on interaction effects is much less than that of F tests on main effects; furthermore, post hocs on differences between the means of final groups cannot circumvent this obstacle when the number of degrees of freedom is strongly reduced.
Fourth, the negative results, including the absence of significant changes in reactivity to different drug challenges, apparently rule out major or widespread neuroteratogenic effects of the pollutant. On the other hand, the selective response changes in different activity tests were suitable to generate specific working hypotheses concerning possible mechanisms of the treatment's action. Specifically, the attenuation of sex differences bears a strong similarity to that observed after developmental exposure to a wide variety of stressors, which suggests that 0 may produce long-lasting neural and endocrine changes like those documented by studies on early stress effects (77, 110) ; this in turn could account for selective medium-and long-term behavioral changes in the absence of direct neuroteratogenic effects.
The data available so far cannot indicate whether the changes produced by 03 exposure resulted from a direct effect on the fetus and the newborn or were the consequence of somatic and behavioral changes in the dams; these data, however, suffice to reject the null (no effect) hypothesis and to characterize developmental 03 exposure as a treatment with a possible risk of borderline neurobehavioral pathology. The significance of this inference obviously depends on both the sensitivity of developing humans relative to that of altricial rodent species and the number of human subjects exposed to concentrations of the same order of magnitude. As concerns the latter, a well-known WHO metaanalysis published in 1987 pointed to peak 03 concentrations often exceeding 0.2 ppm in large, polluted urban areas and to lowest-observed-effect levels in the 0.08 to 0.2 ppm range (111) . A more recent survey in the Paris area showed that 0.05 ppm can produce a significant increase in the frequency and severity of respiratory illnesses in children (112) ; however, information concerning neurobehavioral development of exposed children is apparently not yet available.
Conclusion
This review has attempted to provide both general and specific indications for the effective use of economical test methods in behavioral teratology assessments; in parallel, an attempt has been made to discuss the nature of the information that can reasonably be expected when using one or the othier test strategy.
Some tests, particularly functional observational batteries that can exploit the regularity in postnatal development of several reflexes and responses, have been standardized and validated to the point that their use can be strongly recommended both in proactive studies performed prior to any human exposure and in reactive studies. Other tests, particularly those aimed at assessing motor/exploratory activities, have been and continue to be used in many different versions, often resulting in different profiles of treatment effects as a function of age at testing and other variables.
In spite of this variation of treatment effects, behavioral teratology is coming close to defining the conditions that are most suitable for risk assessment in first-tier proactive studies, with increasing control over possible biases and confounding variables and therefore a progressive abatement of the probability of both false negatives and false positives. In this context, differences in treatment effects as a function of other variables should not be discounted as pure noise or as a nuisance. In fact, they often provide useful preliminary information on treatments' mechanisms of action. In addition, they help in evaluating the functional significance of different CNS changes assessed by neurobiological methods (e.g., in receptor profile, enzyme activity, or neurotransmitter metabolism), which are otherwise difficult to interpret. This applies in particular to ontogenetic dissociations, i.e., differential treatment effects depending jointly on developmental stage at the time of exposure, age of testing, and response end point.
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